share_log

津药药业(600488.SH):子公司产品在全国药品集中采购中拟中选

Tianjin Tianyao Pharmaceuticals (600488.SH): A subsidiary's products are expected to be selected in the national pharmaceutical centralized procurement.

Gelonghui Finance ·  Dec 15 23:59

On December 16, Gelonghui reported that Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its controlling subsidiary, Tianjin Tianyao Heping Pharmaceutical Co., Ltd. (referred to as "Tianyan Heping"), participated in the tenth round of nationwide centralized pharmaceutical procurement organized by the Joint Procurement Office (referred to as "Joint Procurement Office"), with four products: aminophylline injection, fluorouracil injection, methoxamine injection, and methoxamine hydrochloride injection expected to be selected for this centralized procurement.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment